Evotec SE (EVOTF) Preferred Shares (2025 - 2026)

Evotec SE's (EVOTF) quarterly Preferred Shares came in at $1.7 million in Q1 2026, up 0.61% quarter-over-quarter from $1.7 million in Q4 2025.

Evotec SE (EVOTF) Preferred Shares (2025 - 2026) Analysis & Trends

Evotec SE has disclosed Preferred Shares across 2 years of filings, most recently posting $1.7 million for Q1 2026.

Preferred Shares for Q1 2026 came in at $1.7 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (changed N/A YoY), and the FY2025 annual result was $1.7 million, changed N/A from the prior year.
Preferred Shares came in at $1.7 million for Q1 2026 at Evotec SE, up from $1.7 million in the prior quarter.
In the past five years, Preferred Shares ranged from a high of $1.7 million in Q1 2026 to a low of $1.7 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	-
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	-
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	-
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	-
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	-
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	-
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	-
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	-
10	Evotec SE	-	-	-	1.71 Mn

Download Data

Date	Value
Mar 31, 2026	1.71 Mn
Dec 31, 2025	1.70 Mn